Anti-CCP: history and its usefulness

Area of Science:

• Clinical immunology
• Autoantibody detection
• Rheumatoid arthritis diagnostics

Background:

• Antibodies to cyclic citrullinated peptides (anti-CCP) are highly specific biomarkers for rheumatoid arthritis (RA).
• The second-generation anti-CCP test (anti-CCP2) offers improved diagnostic accuracy for RA.
• Commercially available ELISA methods for anti-CCP2 are widely used but can be labor-intensive.

Purpose of the Study:

• To evaluate a new, fully-automated method for anti-CCP2 determination in a routine laboratory setting.
• To compare the performance of the automated assay against a standard commercial ELISA.
• To assess the diagnostic sensitivity and specificity of the new automated anti-CCP2 assay.

Main Methods:

• Serum samples from 543 patients were tested using a commercial anti-CCP2 ELISA.
• The same samples were retested using a pre-launch version of a new automated assay (EliA).
• Comparative analysis of results obtained from both methods was performed.

Main Results:

• The new automated EliA method demonstrated comparable results to the commercial ELISA.
• The automated assay showed high diagnostic sensitivity of 80% and specificity of 97%.
• The EliA system proved to be user-friendly for routine laboratory implementation.

Conclusions:

• The automated EliA assay is a reliable and efficient method for anti-CCP2 detection.
• This automated method is suitable for routine diagnostic laboratories managing rheumatoid arthritis patients.
• The high specificity and sensitivity of the EliA assay support its clinical utility in RA diagnosis.